| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.86B | +33.8% |
| Cost of Revenue | $2.23B | +30.7% |
| Gross Profit | $3.63B | +35.7% |
| R&D Expense | $854.9M | +17.4% |
| SG&A Expense | $119.1M | +27.7% |
| Operating Income | $2.26B | +47.8% |
| Pre-tax Income | $2.42B | +53.1% |
| Income Tax | $334.7M | +45.9% |
| Net Income | $2.09B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.94B | +188.6% |
| Accounts Receivable | $1.02B | +11.0% |
| Inventory | $1.95B | +50.8% |
| Current Assets | $8.39B | +51.2% |
| Total Assets | $9.95B | +46.8% |
| Current Liabilities | $1.91B | +47.6% |
| Total Liabilities | $2.73B | +44.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.03B | +312.7% |
| Investing Cash Flow | -$687.5M | -417.8% |
| Financing Cash Flow | -$83.7M | +87.2% |
| +54.3% |
| EPS (Basic) | $6.75 | +53.1% |
| EPS (Diluted) | $6.58 | +54.1% |
| Stockholders' Equity |
| $7.22B |
| +47.8% |